1.98
Schlusskurs vom Vortag:
$2.01
Offen:
$1.97
24-Stunden-Volumen:
5.77M
Relative Volume:
0.89
Marktkapitalisierung:
$1.27B
Einnahmen:
$2.45B
Nettoeinkommen (Verlust:
$-137.40M
KGV:
-9.607
EPS:
-0.2061
Netto-Cashflow:
$333.90M
1W Leistung:
-2.94%
1M Leistung:
-8.33%
6M Leistung:
-25.28%
1J Leistung:
-48.57%
Clarivate Plc Stock (CLVT) Company Profile
Firmenname
Clarivate Plc
Sektor
Telefon
(207) 433-4000
Adresse
4TH FLOOR, ST. PAUL'S GATE, ST. HELIER
Compare CLVT vs IBM, ACN, INFY, FISV, CTSH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CLVT
Clarivate Plc
|
1.98 | 1.36B | 2.45B | -137.40M | 333.90M | -0.2061 |
|
IBM
International Business Machines Corp
|
223.79 | 203.76B | 68.91B | 10.73B | 12.26B | 11.31 |
|
ACN
Accenture Plc
|
165.93 | 94.28B | 73.10B | 7.94B | 12.58B | 12.52 |
|
INFY
Infosys Ltd Adr
|
12.03 | 47.39B | 20.21B | 3.33B | 3.87B | 0.8084 |
|
FISV
Fiserv Inc
|
53.94 | 27.89B | 21.09B | 3.22B | 4.17B | 5.8948 |
|
CTSH
Cognizant Technology Solutions Corp
|
55.35 | 22.25B | 21.41B | 2.23B | 2.47B | 4.6058 |
Clarivate Plc Stock (CLVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-12-17 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-03 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-07-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-06 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-15 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2023-10-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-09-08 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-08-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-08-04 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-13 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-15 | Fortgesetzt | BofA Securities | Neutral |
| 2023-02-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-12-21 | Fortgesetzt | Citigroup | Buy |
| 2021-12-13 | Fortgesetzt | Goldman | Buy |
| 2021-08-16 | Eingeleitet | BofA Securities | Buy |
| 2021-08-04 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-03-31 | Eingeleitet | Jefferies | Buy |
| 2021-03-11 | Fortgesetzt | Citigroup | Buy |
| 2021-03-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Clarivate Plc Aktie (CLVT) Neueste Nachrichten
Strengthening pharma and medtech joint clinical assessment with AI - Clarivate
Clarivate earnings up next: Value plan faces quarterly test By Investing.com - Investing.com Nigeria
Clarivate PLC (CLVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CLVT|Clarivate PLC|Price:2.125|Chg%:+0.085 - TradingKey
Clarivate PLC (CLVT) Balance Sheet - TradingKey
Clarivate PLC (CLVT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clarivate PLC (CLVT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clarivate PLC (CLVT) Institutional Confidence - TradingKey
Clarivate PLC (CLVT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clarivate PLC (CLVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clarivate PLC Revenue Breakdown – HAN:16A - TradingView
Price to earnings forward of Clarivate PLC – SWB:16A - TradingView
KBC Group NV Makes New Investment in Clarivate PLC $CLVT - MarketBeat
Clarivate PLC $CLVT Shares Sold by Clarkston Capital Partners LLC - MarketBeat
CLVT|Clarivate PLC|Price:2.040|Chg%:+0.100 - TradingKey
Earnings Preview: Clarivate to Report Financial Results Pre-market on July 29 - 富途牛牛
ETFs Investing in Clarivate PLC Stocks - TradingView
CLVT Stock Under Pressure As Barclays Stays Bearish - StocksToTrade
Clarivate (CLVT) Projected to Announce Earnings on Wednesday - MarketBeat
Clarivate PLC (CLVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clarivate: Selling, But Still A Continued Leverage Overhang (NYSE:CLVT) - Seeking Alpha
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers - Macau Business
Clarivate (NYSE:CLVT) Shares Down 5.2%Here's Why - MarketBeat
Clarivate's RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers - Intellectia AI
CMNN5201543 Bond Risk Profile - TradingView
USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate - Sahm
Clarivate (CLVT) Could Be 43% Undervalued After France Library Win - Sahm
Clarivate selected by Singapore's National Library Board for automation solutions - Indiatimes
Clarivate Plc Supports U.S. Patent And Trademark Office In Launching AI Image Search In Trademark Search System - marketscreener.com
Clarivate Supports USPTO with AI Image Search Launch - Intellectia AI
Clarivate (CLVT) Deepens French Library Ties But What Does It Reveal About Its Moat? - Yahoo Finance
Clarivate (CLVT) Wins Abes Contract, Is The 45% Undervaluation Case Convincing? - Yahoo Finance
Clarivate (CLVT) Selected to Upgrade France's Academic Library S - GuruFocus
Is Clarivate (CLVT) Quietly Repositioning as Core Infrastructure for AI-Powered Academic Research Systems? - simplywall.st
Clarivate Selected by Abes to Modernize French National Academic Library System - aap.com.au
Clarivate jumps 16% on $600M sale of life sciences segment - MSN
France's national academic library system to be modernized with Clarivate's cloud platform. - Pluang
Clarivate Plc (CLVT) Q1 2026 Earnings: EPS Surpasses Estimates by Nearly 22%, Shares AdvanceTax Rate Impact - dars.gov.et
Clarivate (CLVT) to Sell Life Sciences & Healthcare Business to Altaris For $600 Million - Yahoo Finance
Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business - MarketBeat
Clarivate to sell life sciences unit to Altaris for $600M, refocus core business - MSN
Clarivate to Report Second Quarter 2026 Results on July 29, 2026 - 富途牛牛
Clarivate Shareholder Notice - TMX Newsfile
Clarivate Update - TMX Newsfile
Enterprise value to revenue forward of Clarivate PLC – MUN:16A - TradingView
Exploring the impact of G20 R&D investment - Clarivate
Improving research funding outcomes with AI‑native research intelligence - Clarivate
Clarivate PLC Actuals & Estimates (TRADEGATE:16A) - TradingView
Latham Advises on Financing for Altaris’ Acquisition of Clarivate’s Life Sciences & Healthcare Business - Latham & Watkins LLP
Clarivate (CLVT) Sells Life Sciences Division for $600 Million - GuruFocus
Clarivate (CLVT) Affirms FY26 Financial Projections Amid Segment Changes - GuruFocus
Finanzdaten der Clarivate Plc-Aktie (CLVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):